Literature DB >> 20567994

Ultraviolet recall dermatitis reaction with sorafenib.

Nicolas Magné1, Cyrus Chargari, Pierre Auberdiac, Coralie Moncharmont, Yacine Merrouche, Jean-Philippe Spano.   

Abstract

PURPOSE: Recall dermatitis is a rare and poorly understood drug-related event. Activated by exposure to sunlight or Ultraviolet (UV), drug-related phototoxic reactions have been reported with conventional chemotherapy agents or antibiotics.
METHODS: Here, we report the first case of acute dermatologic photo-induced recall reaction secondary to sorafenib in a patient with renal cell carcinoma.
RESULTS: Four weeks after stopping sorafenib, a patient with renal cell carcinoma developed an acute erythematous and papulomatous eruption restricted to the hands after prolonged solar exposure. The erythematous region was very well demarcated, mimicking the cutaneous syndrome that the patient had presented at time he was receiving sorafenib.
CONCLUSIONS: The suppression of the phototoxic reaction by corticosteroids strongly suggests that the immune system may have an important function in photo-recall reactions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20567994     DOI: 10.1007/s10637-010-9476-5

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  12 in total

1.  Docetaxel-induced radiation recall dermatitis and successful rechallenge without recurrence.

Authors:  D R Camidge; I H Kunkler
Journal:  Clin Oncol (R Coll Radiol)       Date:  2000       Impact factor: 4.126

2.  Double diagnosis in cancer patients and cutaneous reaction related to gemcitabine: CASE 3. Photo therapy recall with gemcitabine following ultraviolet B treatment.

Authors:  Joanna Badger; Sewon Kang; Alison Uzieblo; Sandy Srinivas
Journal:  J Clin Oncol       Date:  2005-10-01       Impact factor: 44.544

3.  Ultraviolet recall reaction after total body irradiation, etoposide, and methotrexate therapy.

Authors:  Katherine L Goldfeder; Joshua M Levin; Kenneth A Katz; Loren E Clarke; Alison W Loren; William D James
Journal:  J Am Acad Dermatol       Date:  2006-12-20       Impact factor: 11.527

4.  Radiation recall reaction induced by levofloxacin.

Authors:  Sunghun Cho; Jennifer J Breedlove; Sean T Gunning
Journal:  J Drugs Dermatol       Date:  2008-01       Impact factor: 2.114

5.  Radiation recall dermatitis triggered by multi-targeted tyrosine kinase inhibitors: sunitinib and sorafenib.

Authors:  Caroline Chung; Laura A Dawson; Anthony M Joshua; Anthony M Brade
Journal:  Anticancer Drugs       Date:  2010-02       Impact factor: 2.248

Review 6.  [Radiation recall dermatitis after docetaxel and external beam radiotherapy. Report of two cases and review of the literature].

Authors:  N Magné; K Benezery; J Otto; M Namer; J L Lagrange
Journal:  Cancer Radiother       Date:  2002-09       Impact factor: 1.018

7.  Frequency of radiation recall dermatitis in adult cancer patients.

Authors:  Elisabeth Kodym; Renata Kalinska; Christian Ehringfeld; Anneliese Sterbik-Lamina; Reinhard Kodym; Gerda Hohenberg
Journal:  Onkologie       Date:  2005-01

Review 8.  Radiation recall: a well recognized but neglected phenomenon.

Authors:  David Azria; Nicolas Magné; Abderrahim Zouhair; Pierre Castadot; Stéphane Culine; Marc Ychou; Roger Stupp; Paul Van Houtte; Jean-Bernard Dubois; Mahmut Ozsahin
Journal:  Cancer Treat Rev       Date:  2005-09-15       Impact factor: 12.111

9.  Photo recall phenomenon: an adverse reaction to taxanes.

Authors:  Hock-Leong Ee; Gil Yosipovitch
Journal:  Dermatology       Date:  2003       Impact factor: 5.366

10.  Radiation recall dermatitis, panniculitis, and myositis following cyclophosphamide therapy: histopathologic findings of a patient affected by multiple myeloma.

Authors:  Giovanni Borroni; Camilla Vassallo; Valeria Brazzelli; Sara Martinoli; Marco Ardigò; Paolo Emilio Alessandrino; Riccardo Giovanni Borroni; Pietro Franchini
Journal:  Am J Dermatopathol       Date:  2004-06       Impact factor: 1.533

View more
  2 in total

1.  Sorafenib-associated facial acneiform eruption.

Authors:  Philip R Cohen
Journal:  Dermatol Ther (Heidelb)       Date:  2014-12-25

2.  Recall radiation dermatitis by sorafenib following stereotactic body radiation therapy.

Authors:  Chen-Hsi Hsieh; Shih-Chiang Lin; Pei-Wei Shueng; Deng-Yu Kuo
Journal:  Onco Targets Ther       Date:  2014-06-18       Impact factor: 4.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.